7Baggers

Definitive Healthcare
(NASDAQ:DH) 

DH stock logo

Definitive Healthcare Corp., through its subsidiaries, provides healthcare commercial intelligence. It offers information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. The co...

Founded: 2010
IPO Price: $27 (Sep 15, 2021)
CEO: Jason Krantz  
Sector: Healthcare
Industry: Health Information Services
Healthcare
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
                       
      revenue
    		55,929,000 61,534,000 60,046,000 60,750,000 59,191,000 62,288,000 62,697,000 63,737,000 63,480,000 65,932,000 65,325,000 60,957,000 59,201,000 60,599,000 57,382,000 54,548,000 50,124,000 46,313,000 43,084,000 
      yoy
    		-5.51% -1.21% -4.23% -4.69% -6.76% -5.53% -4.02% 4.56% 7.23% 8.80% 13.84% 11.75% 18.11% 30.85% 33.19%     
      qoq
    		-9.11% 2.48% -1.16% 2.63% -4.97% -0.65% -1.63% 0.40% -3.72% 0.93% 7.17% 2.97% -2.31% 5.61% 5.20% 8.83% 8.23% 7.49%  
      cost of revenue:
    		                   
      cost of revenue exclusive of amortization
    		9,355,000 9,944,000 9,069,000 8,800,000 10,141,000 10,967,000 10,077,000 9,904,000 9,736,000 9,447,000 8,663,000 8,078,000 8,552,000 7,149,000 6,569,000 6,198,000    
      amortization
    		4,924,000 4,681,000 4,984,000 5,337,000 5,290,000 3,719,000 3,589,000 3,379,000 3,362,000 3,066,000 3,232,000 3,090,000 3,354,000 2,646,000 3,155,000 5,580,000 5,378,000 5,372,000 5,356,000 
      gross profit
    		41,650,000 46,909,000 45,993,000 46,613,000 43,760,000 47,602,000 49,031,000 50,454,000 50,382,000 53,419,000 53,430,000 49,789,000 47,295,000 50,804,000 47,658,000 42,770,000 38,796,000 35,415,000 32,599,000 
      yoy
    		-4.82% -1.46% -6.20% -7.61% -13.14% -10.89% -8.23% 1.34% 6.53% 5.15% 12.11% 16.41% 21.91% 43.45% 46.19%     
      qoq
    		-11.21% 1.99% -1.33% 6.52% -8.07% -2.91% -2.82% 0.14% -5.69% -0.02% 7.31% 5.27% -6.91% 6.60% 11.43% 10.24% 9.55% 8.64%  
      gross margin %
    		74.47% 76.23% 76.60% 76.73% 73.93% 76.42% 78.20% 79.16% 79.37% 81.02% 81.79% 81.68% 79.89% 83.84% 83.05% 78.41% 77.40% 76.47% 75.66% 
      operating expenses:
    		                   
      sales and marketing
    		19,578,000 20,135,000 20,380,000 20,469,000 20,653,000 20,372,000 20,130,000 21,545,000 21,760,000 23,605,000 22,804,000 24,702,000 23,423,000 23,523,000 21,184,000 23,585,000 21,293,000 17,384,000 14,376,000 
      product development
    		6,499,000 9,954,000 7,553,000 7,968,000 9,301,000 8,982,000 7,282,000 10,122,000 10,132,000 11,569,000 10,759,000 10,229,000 9,884,000 10,129,000 9,205,000 8,706,000 6,850,000 5,748,000 4,746,000 
      general and administrative
    		12,084,000 14,321,000 12,364,000 12,673,000 12,269,000 8,503,000 11,354,000 12,527,000 16,883,000 16,567,000 14,545,000 13,670,000 13,640,000 15,217,000 13,718,000 9,392,000 10,454,000 11,637,000 7,880,000 
      depreciation and amortization
    		8,325,000 9,214,000 9,076,000 9,001,000 8,527,000 9,413,000 9,474,000 9,409,000 9,322,000 9,935,000 9,795,000 9,688,000 9,590,000 10,040,000 10,037,000 10,194,000 9,874,000 9,865,000 9,760,000 
      transaction, integration, and restructuring expenses
    		-765,000 379,000 5,308,000 672,000 1,265,000 2,835,000 -1,995,000 2,851,000 8,534,000 1,823,000 3,505,000 3,571,000 2,590,000       
      goodwill impairment
    		197,219,000 19,533,000   176,531,000 97,060,000 228,153,000 363,641,000   287,400,000         
      total operating expenses
    		242,940,000 73,536,000 54,681,000 50,783,000 228,546,000 147,165,000 274,398,000 420,095,000 66,631,000 63,499,000 348,808,000 61,860,000 59,127,000 60,437,000 57,089,000 53,984,000 49,781,000 47,589,000 36,625,000 
      income from operations
    		-201,290,000 -26,627,000 -8,688,000 -4,170,000 -184,786,000 -99,563,000 -225,367,000 -369,641,000 -16,249,000 -10,080,000 -295,378,000 -12,071,000 -11,832,000 -9,633,000 -9,431,000 -11,214,000 -10,985,000 -12,174,000 -4,026,000 
      yoy
    		8.93% -73.26% -96.14% -98.87% 1037.21% 887.73% -23.70% 2962.22% 37.33% 4.64% 3031.99% 7.64% 7.71% -20.87% 134.25%     
      qoq
    		655.96% 206.48% 108.35% -97.74% 85.60% -55.82% -39.03% 2174.85% 61.20% -96.59% 2347.01% 2.02% 22.83% 2.14% -15.90% 2.08% -9.77% 202.38%  
      operating margin %
    		-359.90% -43.27% -14.47% -6.86% -312.19% -159.84% -359.45% -579.95% -25.60% -15.29% -452.17% -19.80% -19.99% -15.90% -16.44% -20.56% -21.92% -26.29% -9.34% 
      other income, net:
    		                   
      interest income
    		1,297,000 1,482,000 1,668,000 1,749,000 2,052,000 3,206,000 3,742,000 3,717,000 3,927,000 3,774,000 3,464,000 3,572,000 2,834,000       
      interest expense
    		-2,629,000 -2,866,000 -2,999,000 -2,990,000 -2,433,000 -3,509,000 -3,749,000 -3,763,000 -3,816,000 -3,899,000 -3,897,000 -3,793,000 -3,614,000 -1,483,000 -2,466,000 -2,580,000 -1,884,000 -1,915,000 -7,186,000 
      gain on remeasurement of tax receivable agreement liability
    		6,521,000   -2,901,000 20,664,000 8,758,000 24,183,000 41,701,000 2,267,000           
      loss on partial extinguishment of debt
    		    -507,000               
      other income
    		312,000 -272,000 -109,000 -497,000 -969,000 496,000 -357,000 -101,000 373,000 -1,982,000 29,589,000 -797,000  807,000 5,528,000 4,002,000 -101,000   
      total other income
    		5,501,000 9,427,000 -8,580,000 -4,639,000 18,807,000 8,951,000 23,819,000 41,554,000 2,751,000 -2,107,000 29,156,000 -1,018,000  -676,000 3,062,000 1,422,000    
      net loss before income taxes
    		-195,789,000 -48,014,000 -17,268,000 -8,809,000 -165,979,000 -135,783,250 -201,548,000 -328,087,000 -13,498,000 -73,998,250 -266,222,000 -13,089,000 -16,310,000   -9,792,000 -12,970,000   
      benefit from income taxes
    		3,435,000 53,000 -524,000 -456,000 10,886,000 5,895,000 13,724,000 21,900,000 780,000 -1,175,000 17,534,000 1,484,000 710,000       
      net income
    		-192,354,000 -17,147,000 -17,792,000 -9,265,000 -155,093,000 -84,717,000 -187,824,000 -306,187,000 -12,718,000 -13,362,000 -248,688,000 -11,605,000 -15,600,000 6,735,000 -6,354,000 -9,579,000 -13,057,000 -14,764,000 -20,966,000 
      yoy
    		24.02% -79.76% -90.53% -96.97% 1119.48% 534.01% -24.47% 2538.41% -18.47% -298.40% 3813.88% 21.15% 19.48% -145.62% -69.69%     
      qoq
    		1021.79% -3.63% 92.03% -94.03% 83.07% -54.90% -38.66% 2307.51% -4.82% -94.63% 2042.94% -25.61% -331.63% -206.00% -33.67% -26.64% -11.56% -29.58%  
      net income margin %
    		-343.93% -27.87% -29.63% -15.25% -262.02% -136.01% -299.57% -480.39% -20.03% -20.27% -380.69% -19.04% -26.35% 11.11% -11.07% -17.56% -26.05% -31.88% -48.66% 
      less: net loss attributable to noncontrolling interests
    		-53,733,000 -7,832,000 -2,954,000 -1,714,000 -47,865,000 -25,642,000 -56,928,000 -92,552,000 -3,200,000 -3,129,000 -77,162,000 -3,039,000 -3,783,000   -4,429,000 -4,433,000 -5,065,000 -5,172,000 
      net loss attributable to definitive healthcare corp.
    		-138,621,000 -9,315,000 -14,838,000 -7,551,000 -107,228,000 -59,075,000 -130,896,000 -213,635,000 -9,518,000 -10,233,000 -171,526,000 -8,566,000 -11,817,000   -5,150,000 -8,624,000 -9,699,000 -7,978,000 
      net income per share
    		                   
      basic and diluted
    		-1.32 -0.1 -0.14 -0.07 -0.95 -0.52 -1.12 -1.81 -0.08 -0.07 -1.5 -0.08 -0.11 0.1 -0.03 -0.05 -0.09 -0.1 -0.09 
      weighted-average class a common stock outstanding:
    		                   
      basic and diluted
    		104,675,068 106,650,845 103,783,012 106,815,740 112,782,505 116,640,183 116,382,021 117,750,392 117,433,520 112,764,537 114,527,514 111,768,782 108,234,043 101,114,105 102,904,565 99,203,697 97,158,823 91,916,151 88,263,333 
      gain on remeasurement of tra liability
    		 2,655,750 -7,140,000                 
      other expense
    		            -3,698,000       
      total other expense
    		            -4,478,000    -1,985,000 -1,915,000 -16,940,000 
      transaction, integration and restructuring expenses
    		             1,590,500 2,945,000     
      loss on extinguishment of debt
    		                  -9,873,000 
      net income before income taxes
    		             -7,282,750 -6,369,000     
      income tax benefit
    		             35,250 15,000 213,000    
      less: net income attributable to definitive opco prior to the reorganization transactions
    		                   
      less: net income attributable to noncontrolling interests
    		             -3,131,750 -3,665,000     
      net income attributable to definitive healthcare corp.
    		             -4,115,750 -2,689,000     
      transaction and restructuring expenses
    		               2,107,000    
      less: net loss attributable to definitive opco prior to the reorganization transactions
    		                 -8,335,750 -7,816,000 
      cost of revenue exclusive of amortization shown below
    		                5,950,000 5,526,000 5,129,000 
      transaction expenses
    		                1,310,000 2,955,000 -137,000 
      other expense, net:
    		                   
      provision for income taxes
    		                -87,000   
      foreign currency transaction gain
    		                  119,000 
      weighted-average common stock outstanding:
    		                   
      basic and diluted
    		104,675,068 106,650,845 103,783,012 106,815,740 112,782,505 116,640,183 116,382,021 117,750,392 117,433,520 112,764,537 114,527,514 111,768,782 108,234,043 101,114,105 102,904,565 99,203,697 97,158,823 91,916,151 88,263,333 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 
                         
        assets
      		                   
        current assets:
      		                   
        cash and cash equivalents
      		157,648,000 163,627,000 108,317,000 80,984,000 106,099,000 105,378,000 137,609,000 120,901,000 105,994,000 130,976,000 77,460,000 132,385,000 124,961,000 146,934,000 228,828,000 228,202,000 229,795,000 387,498,000 189,752,000 
        short-term investments
      		20,447,000 17,262,000 77,607,000 103,217,000 94,574,000 184,786,000 167,779,000 175,612,000 189,174,000 177,092,000 229,565,000 218,515,000 218,955,000 184,939,000 120,798,000 118,216,000 109,027,000   
        accounts receivable
      		38,941,000 51,978,000 34,371,000 37,507,000 42,923,000 53,232,000 35,754,000 44,180,000 56,655,000 59,249,000 41,308,000 44,519,000 51,801,000 58,799,000 33,689,000 31,734,000 38,465,000 43,336,000 27,886,000 
        prepaid expenses and other assets
      		16,279,000 11,972,000 13,213,000 14,305,000 16,173,000 13,040,000 14,049,000 13,927,000 13,296,000 13,120,000          
        deferred contract costs
      		12,441,000 12,766,000 12,809,000 13,181,000 13,673,000 13,736,000 13,486,000 13,701,000 13,598,000 13,490,000          
        total current assets
      		245,756,000 257,605,000 246,317,000 249,194,000 273,442,000 370,172,000 368,677,000 368,321,000 378,717,000 393,927,000 375,396,000 421,042,000 421,492,000 413,745,000 402,210,000 396,212,000 392,152,000 444,232,000 226,639,000 
        property and equipment
      		13,798,000 12,680,000 11,658,000 10,512,000 9,483,000 3,791,000 3,704,000 3,526,000 4,100,000 4,471,000 4,628,000 4,488,000 4,452,000 4,464,000 4,581,000 4,760,000 4,818,000 5,069,000 4,697,000 
        operating lease right-of-use assets
      		4,880,000 5,394,000 6,145,000 6,604,000 6,982,000 7,521,000 8,274,000 7,840,000 9,022,000 9,594,000 9,951,000 8,697,000 9,118,000 9,681,000 10,051,000 10,552,000 18,811,000   
        other assets
      		2,578,000 2,277,000 1,813,000 2,578,000 2,991,000 2,300,000 1,989,000 1,946,000 1,978,000 2,388,000 3,414,000 3,938,000 3,697,000 4,683,000 5,105,000 3,243,000 2,876,000 8,273,000 747,000 
        intangible assets
      		235,433,000 247,477,000 260,081,000 271,237,000 284,708,000 297,933,000 294,530,000 307,023,000 317,972,000 323,121,000 336,027,000 325,794,000 338,295,000 350,722,000 361,703,000 372,196,000 387,241,000 352,470,000 366,723,000 
        goodwill
      		 197,219,000 216,752,000 216,752,000 216,752,000 393,283,000 490,343,000 718,496,000 1,082,137,000 1,075,080,000 1,073,986,000 1,324,733,000 1,323,102,000 1,323,102,000 1,322,959,000 1,322,959,000 1,323,516,000 1,261,444,000 1,261,444,000 
        total assets
      		514,738,000 735,492,000 755,527,000 770,145,000 808,657,000 1,089,389,000 1,181,653,000 1,422,420,000 1,810,145,000 1,825,901,000 1,819,534,000 2,104,863,000 2,115,236,000 2,120,993,000 2,119,773,000 2,122,855,000 2,141,728,000 2,115,988,000 1,869,799,000 
        liabilities and equity
      		                   
        current liabilities:
      		                   
        accounts payable
      		6,024,000 3,596,000 8,572,000 7,898,000 8,218,000 10,763,000 9,961,000 6,078,000 4,895,000 5,787,000 5,567,000 3,650,000 4,535,000 3,948,000 10,266,000 6,692,000 6,207,000 4,651,000 7,055,000 
        accrued expenses and other liabilities
      		23,916,000 44,773,000 41,914,000 31,271,000 26,963,000 40,896,000 35,751,000 34,229,000 35,950,000 51,529,000          
        deferred revenue
      		99,055,000 96,989,000 91,984,000 100,874,000 109,724,000 93,344,000 86,219,000 97,062,000 108,078,000 97,377,000    236,000 504,000 278,000 387,000 412,000 368,000 
        term loan
      		8,750,000 8,750,000 8,750,000 8,750,000 8,750,000 13,750,000 13,750,000 13,750,000 13,750,000 13,750,000          
        operating lease liabilities
      		2,657,000 2,679,000 2,661,000 2,459,000 2,422,000 2,408,000 2,495,000 2,361,000 2,307,000 2,239,000          
        total current liabilities
      		140,402,000 156,787,000 153,881,000 151,252,000 156,077,000 161,161,000 148,176,000 153,480,000 164,980,000 170,682,000 147,142,000 148,127,000 142,620,000 132,503,000 121,552,000 119,188,000 122,015,000 117,795,000 103,037,000 
        long term liabilities:
      		                   
        tax receivable agreement liability
      		12,378,000 19,212,000                  
        deferred tax liabilities
      		11,087,000 14,634,000 14,551,000 14,288,000 13,912,000 25,088,000 30,767,000 44,625,000 66,615,000 67,163,000 65,461,000 78,569,000 78,315,000 75,737,000 91,533,000 85,596,000 86,144,000 75,888,000 71,341,000 
        other liabilities
      		1,622,000 2,247,000 2,884,000 3,446,000 7,413,000 9,449,000 7,171,000 10,544,000 10,403,000 9,934,000          
        total liabilities
      		324,039,000 356,500,000 365,857,000 358,912,000 372,752,000 482,195,000 486,093,000 536,132,000 615,114,000 626,727,000 616,084,000 649,404,000 645,785,000 633,772,000 642,251,000 634,155,000 644,463,000 612,726,000 586,715,000 
        equity:
      		                   
        class a common stock
      		105,000 104,000 103,000 105,000 110,000 114,000 115,000 117,000 118,000 117,000 116,000 113,000 110,000 105,000 105,000 100,000 98,000 97,000 88,000 
        class b common stock
      		                   
        additional paid-in capital
      		1,065,811,000 1,061,965,000 1,056,482,000 1,060,200,000 1,071,732,000 1,085,445,000 1,087,555,000 1,094,217,000 1,095,482,000 1,086,581,000 1,077,332,000 1,050,714,000 1,020,709,000 972,077,000 962,874,000 929,842,000 899,485,000 890,724,000 700,773,000 
        accumulated other comprehensive deficit
      		-1,555,000 -1,450,000 -1,544,000 -1,337,000 -1,264,000               
        accumulated deficit
      		-918,127,000 -779,506,000 -770,191,000 -755,353,000 -747,802,000 -640,574,000 -581,499,000 -450,603,000 -236,968,000 -227,450,000 -217,217,000 -45,691,000 -35,531,000 -23,714,000 -34,140,000 -31,451,000 -26,301,000 -17,677,000 -7,978,000 
        noncontrolling interests
      		44,465,000 97,879,000 104,820,000 107,618,000 113,129,000 162,819,000 189,045,000 241,500,000 334,741,000 337,817,000 340,168,000 447,071,000 481,370,000 535,085,000 544,772,000 588,215,000 623,065,000 630,056,000 590,177,000 
        total equity
      		190,699,000 378,992,000 389,670,000 411,233,000 435,905,000 607,194,000 695,560,000 886,288,000 1,195,031,000 1,199,174,000 1,203,450,000 1,455,459,000 1,469,451,000 1,487,221,000 1,477,522,000 1,488,700,000 1,497,265,000 1,503,262,000 1,283,084,000 
        total liabilities and equity
      		514,738,000 735,492,000 755,527,000 770,145,000 808,657,000 1,089,389,000 1,181,653,000 1,422,420,000 1,810,145,000 1,825,901,000 1,819,534,000 2,104,863,000 2,115,236,000 2,120,993,000 2,119,773,000 2,122,855,000 2,141,728,000 2,115,988,000 1,869,799,000 
        long-term liabilities:
      		                   
        commitments and contingencies
      		                   
        tra liability
      		  30,510,000                 
        tax receivable agreements liability
      		   22,605,000 23,124,000 49,511,000 59,013,000 83,391,000 125,150,000 127,000,000    156,311,000 157,175,000 155,900,000 154,673,000 153,529,000 146,106,000 
        accumulated other comprehensive (deficit) income
      		     -610,000              
        accumulated other comprehensive income
      		      344,000 1,057,000 1,658,000 2,109,000 3,051,000 3,252,000 2,793,000 3,668,000 3,911,000 1,994,000 918,000 62,000 24,000 
        deferred contract costs, net of current portion
      		         17,320,000 16,132,000 16,171,000 15,080,000 14,596,000 13,164,000 12,933,000 12,314,000 11,667,000 9,388,000 
        prepaid expenses and other current assets
      		          14,667,000 13,734,000 14,711,000 12,686,000 9,716,000 9,591,000 7,208,000 6,518,000 3,642,000 
        current portion of deferred contract costs
      		          12,396,000 11,889,000 11,064,000 10,387,000 9,179,000 8,469,000 7,657,000 6,880,000 5,359,000 
        accrued expenses and other current liabilities
      		          35,986,000 33,238,000 20,770,000 18,748,000 18,885,000 14,682,000 12,837,000 22,658,000 19,296,000 
        current portion of deferred revenue
      		          89,713,000 97,495,000 105,362,000 99,692,000 83,820,000 88,714,000 93,574,000 83,611,000 69,811,000 
        current portion of term loan
      		          13,750,000 12,031,000 10,313,000 8,594,000 6,875,000 6,875,000 6,875,000 6,875,000 6,875,000 
        current portion of operating lease liabilities
      		          2,126,000 1,713,000 1,640,000 1,521,000 1,706,000 2,225,000 2,522,000   
        deferred revenue, net of current portion
      		          68,000 150,000 138,000       
        term loan, net of current portion
      		          245,866,000 249,166,000 252,465,000 255,765,000 259,064,000 260,646,000 262,226,000 263,808,000 265,388,000 
        operating lease liabilities, net of current portion
      		          9,873,000 9,004,000 9,491,000 9,969,000 10,450,000 10,596,000 17,728,000   
        tax receivable agreements liability, net of current portion
      		          138,736,000 163,298,000 161,721,000       
        other long-term liabilities
      		          8,938,000 1,090,000 1,035,000 3,251,000 1,973,000 1,951,000 1,290,000 1,294,000 475,000 
        investment in equity securities
      		                 32,675,000  
        deferred tax asset
      		                 158,000 161,000 
        liabilities and total equity
      		                   
        members' equity
      		                   
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 
                          
          cash flows from operating activities:
        		                  
          net loss
        		-192,354,000 -17,147,000 -17,792,000 -9,265,000 -155,093,000 -84,717,000 -187,824,000 -306,187,000 -12,718,000 -13,362,000 -248,688,000 -11,977,000 -15,600,000   -9,579,000 -13,057,000  
          adjustments to reconcile net loss to net cash from operating activities:
        		                  
          depreciation and amortization
        		1,004,000 991,000 853,000 868,000 591,000 526,000 562,000 603,000 554,000 562,000 432,000 446,000 513,000 472,000 469,000 727,000 525,000 558,000 
          amortization of intangible assets
        		12,245,000 12,904,000 13,207,000 13,470,000 13,226,000 12,606,000 12,501,000 12,185,000 12,130,000 12,439,000 12,595,000 12,332,000 12,431,000 12,214,000 12,723,000 15,047,000 14,727,000 14,679,000 
          amortization of deferred contract costs
        		3,740,000 3,940,000 3,996,000 3,988,000 3,947,000 3,978,000 3,943,000 3,828,000 3,692,000 3,488,000 3,445,000 3,170,000 2,860,000 2,542,000 2,283,000 2,116,000 1,875,000 1,598,000 
          equity-based compensation
        		5,220,000 8,161,000 6,684,000 6,980,000 7,319,000 7,365,000 6,296,000 8,842,000 15,582,000 13,254,000 11,994,000 12,363,000 11,128,000 11,424,000 9,133,000 9,005,000 6,872,000 5,619,000 
          amortization of debt issuance costs
        		159,000 139,000 131,000 123,000 126,000 175,000 176,000 175,000 176,000 175,000 176,000 175,000 176,000 175,000 176,000 175,000 176,000 176,000 
          benefit from doubtful accounts receivable
        		-208,000                  
          loss on partial extinguishment of debt
        		 0 0 0 507,000              
          non-cash restructuring charges
        		 243,000 160,000 0 192,000     0 -143,000        
          goodwill impairment charges
        		197,219,000 19,533,000 0 0 176,531,000 97,060,000             
          tax receivable agreement remeasurement
        		-6,521,000   2,901,000 -20,664,000 -8,758,000 -24,183,000 -41,701,000 -2,267,000 1,507,000 -29,675,000 1,079,000 3,619,000 -1,078,000 -5,153,000 -3,391,000 248,000  
          changes in fair value of contingent consideration
        		 0 -3,280,000 0 -690,000 1,460,000 -3,510,000 0 270,000         595,000 
          deferred income taxes
        		-3,537,000 -568,000 299,000 398,000 -11,007,000 -6,061,000 -13,774,000 -21,988,000 -847,000 1,015,000 -17,304,000 -1,651,000 -773,000 -17,087,000 -42,000 -233,000 69,000  
          changes in operating assets and liabilities:
        		                  
          accounts receivable
        		13,259,000 -17,967,000 3,477,000 5,523,000 10,351,000 -17,455,000 7,948,000 12,201,000 2,999,000 -18,559,000 5,486,000 6,918,000 6,966,000 -25,676,000 -2,816,000 6,744,000 8,526,000 -15,905,000 
          prepaid expenses and other assets
        		-4,022,000 1,232,000 749,000 1,453,000 -5,683,000 -627,000 -2,947,000 -2,859,000 -1,399,000          
          deferred contract costs
        		-2,868,000 -3,976,000 -3,117,000 -2,465,000 -3,794,000 -4,481,000 -2,596,000 -2,980,000 -2,699,000 -5,770,000 -3,913,000 -5,086,000 -4,021,000 -5,182,000 -3,224,000 -3,547,000 -3,299,000 -5,398,000 
          accounts payable, accrued expenses, and other liabilities
        		-11,573,000 -1,441,000 12,498,000 -3,400,000 -8,745,000 -285,000 5,116,000 -2,058,000 -8,231,000  1,434,000 1,271,000 -4,294,000      
          deferred revenue
        		-199,000 7,356,000 -9,471,000 -11,091,000 19,094,000 7,157,000 -10,848,000 -11,026,000 9,738,000 7,533,000 -11,869,000 -7,813,000 5,569,000 15,714,000 -4,702,000 -4,571,000 6,249,000 13,938,000 
          net cash from operating activities
        		11,564,000 2,720,000 15,687,000 9,304,000 26,066,000 8,135,000 19,432,000 14,040,000 16,589,000 4,709,000 9,487,000 12,037,000 14,957,000 -4,220,000 10,685,000 15,481,000 13,633,000 4,219,000 
          capital expenditures
        		-3,202,000 0 -2,281,000 -2,293,000 -7,706,000 -10,901,000 -767,000 -410,000 -266,000 -594,000 -305,000 -740,000 -1,338,000 0 -1,878,000 -783,000 -794,000 0 
          free cash flows
        		8,362,000 2,720,000 13,406,000 7,011,000 18,360,000 -2,766,000 18,665,000 13,630,000 16,323,000 4,115,000 9,182,000 11,297,000 13,619,000 -4,220,000 8,807,000 14,698,000 12,839,000 4,219,000 
          cash flows from investing activities:
        		                  
          purchases of property, equipment, and data assets
        		-3,202,000                  
          purchases of short-term investments
        		-12,500,000 0 0 -52,065,000 -12,000,000 -111,634,000 -68,724,000 -40,120,000 -83,826,000 -45,595,000 -80,814,000 -42,547,000 -90,252,000 -120,695,000 -54,309,000 -53,398,000 -109,559,000  
          maturities of short-term investments
        		9,481,000 60,791,000 26,422,000 44,196,000 103,251,000 96,265,000 78,452,000 55,464,000 73,588,000 100,596,000 72,083,000 44,627,000 58,120,000 57,680,000 52,000,000    
          net cash from investing activities
        		-6,221,000 56,351,000 24,141,000 -10,162,000 83,545,000 -26,270,000 8,961,000 14,934,000 -24,034,000 54,407,000 -54,059,000 1,340,000 -33,470,000 -67,886,000 -3,984,000 -10,181,000 -166,852,000 -41,069,000 
          cash flows from financing activities:
        		                  
          repayments of term loan
        		-2,188,000  -2,187,000 -2,188,000 -246,250,000              
          proceeds from term loan
        		 0 0 0 175,000,000             0 
          payments of debt issuance costs
        		 0 0 0 -1,660,000              
          taxes paid related to net share settlement of equity awards
        		-926,000 -1,402,000 -1,063,000 -609,000 -1,874,000 -278,000 -495,000 -969,000 -5,806,000 -1,035,000 -782,000 -1,085,000 -1,530,000 -1,371,000     
          repurchases of class a common stock
        		 0 -9,221,000 -19,076,000 -21,155,000 -7,329,000 -8,034,000            
          payments under tax receivable agreement
        		-7,762,000   0 -13,767,000 0 0 0 -6,950,000 0 0 0 -246,000      
          net cash from financing activities
        		-10,876,000 -3,911,000 -12,471,000 -24,700,000 -109,706,000 -13,368,000 -12,065,000 -14,122,000 -17,194,000 -6,062,000 -10,366,000 -5,631,000 -3,525,000 -9,457,000 -6,115,000 -6,748,000 -4,376,000 234,677,000 
          net decrease in cash and cash equivalents
        		-5,533,000   -25,558,000 -95,000 -31,503,000 16,328,000 14,852,000 -24,639,000  -54,938,000 7,746,000 -22,038,000      
          effect of exchange rate changes on cash and cash equivalents
        		-446,000 150,000 -24,000 443,000 816,000 -728,000 380,000 55,000 -343,000 462,000 13,000 -322,000 65,000 -331,000 40,000 -145,000 -108,000 -81,000 
          cash and cash equivalents, beginning of period
        		163,627,000  0 0 105,378,000  0 0 130,976,000  0 0 146,934,000  0 0 387,498,000 0 
          cash and cash equivalents, end of period
        		157,648,000  27,333,000 -25,115,000 106,099,000  16,708,000 14,907,000 105,994,000  -54,925,000 7,424,000 124,961,000  626,000 -1,593,000 229,795,000 197,746,000 
          supplemental cash flow disclosures:
        		                  
          cash paid during the period for:
        		                  
          interest
        		2,472,000  2,870,000 2,959,000 2,242,000  3,654,000 3,590,000 3,642,000  3,681,000 3,616,000 3,475,000  2,898,000 2,579,000 1,771,000  
          income taxes
        		93,000  176,000 0 32,000      0 57,000 79,000      
          supplemental disclosure of non-cash investing activities:
        		                  
          capital expenditures included in accounts payable and accrued expenses and other liabilities
        		3,758,000  1,764,000 -446,000 5,393,000  -6,000            
          write-off of deferred offering costs
        		 0                 
          (recovery of) provision for bad debt expense
        		                  
          contingent consideration
        		     0 0 0 -602,000     0 0 0 -6,400,000  
          cash paid for acquisitions and investments, net of cash acquired
        		                  
          repayments of term loans
        		     -3,437,000 -3,438,000 -3,437,000 -3,438,000  -1,718,000 -1,719,000 -1,719,000  -1,718,000 -1,719,000 -1,719,000  
          payments of contingent consideration
        		     0 0            
          payments of equity offering issuance costs
        		         0 0 0 -30,000 -435,000 0 0 -1,299,000  
          member distributions
        		 -321,000 0   -2,324,000 -98,000   -1,589,000 -7,866,000   -5,932,000 -1,652,000 -5,029,000 -258,000 -989,000 
          net increase in cash and cash equivalents
        		 55,160,000            -81,563,000 586,000 -1,448,000 -157,595,000 197,827,000 
          cash and cash equivalents, beginning of year
        		                  
          cash and cash equivalents, end of year
        		                  
          (recovery of) provision for doubtful accounts receivable
        		  -314,000                
          tra remeasurement
        		                  
          purchases of property, equipment, and other assets
        		  -2,281,000 -2,293,000 -7,706,000 -10,901,000 -767,000 -410,000 -266,000 -594,000 -305,000 -740,000 -1,338,000      
          cash paid for acquisitions, net of cash acquired
        		      0 0 -13,530,000      203,000 0 -56,499,000  
          payments under tra
        		                  
          acquisitions:
        		                  
          net assets acquired, net of cash acquired
        		      0 0 13,675,000      -203,000 0 97,499,000  
          working capital adjustment receivable
        		      0 0 -145,000          
          net cash paid for acquisitions
        		      0 0 13,530,000      -203,000 0 56,499,000  
          provision for doubtful accounts receivable
        		    -142,000  419,000 317,000 211,000 554,000 354,000 444,000 22,000    9,000 556,000 
          provision for bad debt expense
        		                  
          non-cash impairment charges related to office leases
        		      0            
          goodwill impairment charge
        		         0         
          payment of contingent consideration
        		        -1,000,000     0 0 0 -1,100,000 0 
          capital expenditures included in accrued expenses and other liabilities
        		                  
          loss on extinguishment of debt
        		                 0 
          accounts payable, accrued expenses and other liabilities
        		                  
          repayments of term loans and delayed draw term loan
        		                  
          payment of debt issuance costs
        		                 0 
          proceeds from equity offering, net of underwriting discounts
        		                  
          repurchase of outstanding equity / definitive opco units
        		                  
          member contributions
        		                 0 
          prepaid expenses and other current assets
        		          -2,237,000 225,000 -3,796,000 -2,681,000 1,235,000 627,000 692,000 -3,168,000 
          initial cash investment in prior year
        		              0 0 -40,000,000  
          capital expenditures included in accounts payable and accrued expenses
        		                  
          supplemental disclosure of non-cash financing activities:
        		                  
          unpaid equity offering costs included in accrued expenses
        		                  
          capital expenditures included in accrued expenses
        		           -273,000 333,000  1,004,000 0 3,500,000  
          non-cash restructuring charges related to office leases
        		            157,000 0 0    
          net income
        		             6,735,000     
          adjustments to reconcile net income to net cash from operating activities:
        		                  
          noncash paid in-kind interest expense
        		                  
          proceeds from delayed draw term loan
        		                  
          proceeds from revolving credit facility
        		                  
          repayments of revolving credit facility
        		                  
          allowance for doubtful accounts
        		              763,000    
          accounts payable, accrued expenses and other current liabilities
        		              6,194,000 1,341,000 -3,579,000 5,053,000 
          cash flows used in investing activities:
        		                  
          purchases of property, equipment and other assets
        		              -1,878,000 -783,000 -794,000  
          cash flows used in financing activities:
        		                  
          cash paid for income taxes
        		                  
          decrease in accrued purchases of data
        		                  
          unpaid public offering costs included in accrued expenses
        		                  
          proceeds from equity offerings, net of underwriting discounts
        		                  
          repurchase of outstanding equity/definitive opco units
        		                  
          noncash paid in kind interest expense
        		                  
          payments of ipo issuance costs
        		                  
          cash paid for interest
        		                  
          net decrease in accrued capital expenditures, including purchases of data
        		                  
          increase in unpaid public offering costs